Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Sabag, Adi D ^a   Bode, Julia ^b   Fink, Dorit ^a   Kigel, Boaz ^a   Kugler, Wilfried ^b   Neufeld, Gera ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SEMAPHORIN; RECOMBINANT SEMAPHORIN 3A; RECOMBINANT SEMAPHORIN 3B; RECOMBINANT SEMAPHORIN 3D; RECOMBINANT SEMAPHORIN 3E; RECOMBINANT SEMAPHORIN 3F; RECOMBINANT SEMAPHORIN 3G; SEMAPHORIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BRAIN CORTEX; CANCER INHIBITION; CELL STRUCTURE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; BRAIN; CELL LINE; CELL LINE, TUMOR; CEREBRAL CORTEX; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; SEMAPHORINS;

EID: 84865293539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042912     Document Type: Article

References (30)

1. Kaur B, Tan C, Brat DJ, Post DE, Van Meir EG, (2004) Genetic and hypoxic regulation of angiogenesis in gliomas. J Neurooncol 70: 229-243.
2. Salmaggi A, Eoli M, Frigerio S, Silvani A, Gelati M, et al. (2003) Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma. J Neurooncol 62: 297-303.
3. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, et al. (2002) The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12: 13-19.
4. Neufeld G, Kessler O, (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8: 632-645.
5. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, et al. (1996) Selective binding of VEGF121 to one of the three VEGF receptors of vascular endothelial cells. J Biol Chem 271: 5519-5523.
6. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M, (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 92: 735-745.
7. Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G, (2000) Neuropilin-2 and Neuropilin-1 are receptors for 165-amino acid long form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145 amino acid form of VEGF. J Biol Chem 275: 18040-18045.
8. Sulpice E, Plouet J, Berge M, Allanic D, Tobelem G, et al. (2007) Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 111: 2036-2045.
9. Gu C, Yoshida Y, Livet J, Reimert DV, Mann F, et al. (2005) Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307: 265-268.
10. Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, et al. (1999) Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99: 59-69.
11. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, et al. (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80.
12. Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, et al. (2001) Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci U S A 98: 13954-13959.
13. Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, et al. (2002) Semaphorin 3F Gene from Human 3p21.3 Suppresses Tumor Formation in Nude Mice. Cancer Res 62: 2637-2643.
14. Kigel B, Varshavsky A, Kessler O, Neufeld G, (2008) Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PLoS ONE 3: e3287.
15. Kessler O, Shraga-Heled N, Lange T, Gutmann-Raviv N, Sabo E, et al. (2004) Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis. Cancer Res 64: 1008-1015.
16. Casazza A, Fu X, Johansson I, Capparuccia L, Andersson F, et al. (2011) Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models. Arterioscler Thromb Vasc Biol pp. 741-749.
17. Maione F, Molla F, Meda C, Latini R, Zentilin L, et al. (2009) Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest 119: 3356-3372.
18. Sakurai A, Gavard J, nnas-Linhares Y, Basile JR, Amornphimoltham P, et al. (2010) Semaphorin 3E initiates anti-angiogenic signaling through Plexin-D1 by regulating Arf6 and R-Ras. Mol Cell Biol 30: 3086-3098.
19. Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, et al. (2008) Semaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases. Cancer Res 68: 6922-6931.
20. Casazza A, Kigel B, Maione F, Capparuccia L, Kessler O, et al. (2012) Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. EMBO Mol Med 4: 234-250.
21. Acevedo LM, Barillas S, Weis SM, Gothert JR, Cheresh DA, (2008) Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111: 2674-2680.
22. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N, (2003) Angiogenesis assays: a critical overview. Clin Chem 49: 32-40.
23. Vacca A, Scavelli C, Serini G, Di PG, Cirulli T, et al. (2006) Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 108: 1661-1667.
24. Moriya J, Minamino T, Tateno K, Okada S, Uemura A, et al. (2010) Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis. Circ Res 106: 391-398.
25. Bagci T, Wu JK, Pfannl R, Ilag LL, Jay DG, (2009) Autocrine semaphorin 3A signaling promotes glioblastoma dispersal. Oncogene 28: 3537-3550.
26. Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G, (2011) Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood 118: 4285-4296.
27. Akiri G, Cherian MM, Vijayakumar S, Liu G, Bafico A, et al. (2009) Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene 28: 2163-2172.
28. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, et al. (2007) Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis. J Biol Chem 282: 26294-26305.
29. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, et al. (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484.
30. Vamesu S, (2007) Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies. Rom J Morphol Embryol 48: 25-31.